Ambys Medicines
Priyadarshini Podishetti has worked in the pharmaceutical industry since 2013, beginning their career as a Validation Consultant at Novartis Pharmaceuticals. Priyadarshini then moved to DePuy Synthes Companies in 2014 as a Validation Engineer. In 2015, they worked as a Validation Engineer at Baxter Pharmaceutical Solutions LLC and a Quality Engineer at Gilead Sciences. In 2017, they became a Validation Specialist at Bayer. Priyadarshini then served as a Validation Engineer at both Gilead Sciences and Siemens in 2018. Currently, they are a Senior Quality Assurance Engineer at Ambys Medicines.
Priyadarshini Podishetti completed their Bachelor's degree in Pharmacy from Osmania University in 2010. Priyadarshini then went on to obtain their Master's degree in Regulatory Affairs for Drugs, Medical Devices and Bilogics from Northeastern University in 2012.
Ambys Medicines
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet the urgent need for treatments that have the potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today.